Hammock-Bellien Labs: Enzyme Research May Have Beneficial Implications in Cardiac Biology
March 17, 2022
A newly published paper in the Journal of Advanced Research, a collaboration of the Bruce Hammock laboratory at the University of California, Davis, and a team of 40 researchers led by Professor Jeremy Bellien of the Department of Pharmacology, Rouen University Hospital, France, sheds new light on enzymes that may have beneficial implications in cardiac biology.
March 21, 2022
Every year some 10,000 burn victims in the United States undergo an acute inflammatory reaction and die of burn-related infections, according to the Centers for Disease Control and Prevention.
February 23, 2022
Professor Bruce Hammock, who co-authored the research, discussed the findings in a new study from the Bruce Hammock laboratory at UC Davis that could alleviate neuroinflammation in Parkinson’s disease.
February 21, 2022
A natural product from the dried root of a pea-family plant, potentially combined with an enzyme inhibitor discovered in the Bruce Hammock laboratory at the University of California, Davis, may provide hope in alleviating neuroinflammation in Parkinson's disease, an eight-member team of researchers from Dalian Medical University, China, and UC Davis announced today.
January 21, 2022
If the University of California, Davis, were to lose electrical power, distinguished professor Bruce Hammock's humorous “back-up plan” at his Briggs Hall office would make antique collectors drool—and his administrative staff cringe over just the thought of preparing a 986-page grant application on his “back-up typewriter.”
October 21, 2021
A research laboratory that collaborates with UC Davis distinguished professor Bruce Hammock on cancer research, using nanobodies from camelids and gene therapy to target tumors, has been named the State Key Laboratory for Nanobodies in the Guangxi Province, China.
June 8, 2021
Three UC Davis scientists, including distinguished professor Bruce Hammock, are part of the Who's Who “click-chemistry team” that won the Royal Society of Chemistry's Horizon Team Award for advancing chemistry and “pushing the boundaries of science.”
Biomarker suggests severity of COVID-19 respiratory distress: Higher levels of certain fatty acids predicted poorer outcomes in COVID-19 patients with acute respiratory distress in a new NIEHS-funded study led by Bruce Hammock
In a study funded in part by NIEHS, researchers reported April 1 that certain fatty acids in the blood of COVID-19 patients may predict the severity of adult respiratory distress syndrome (ARDS). The fatty acids may also offer a target for treatment. ARDS, characterized by fluid buildup in the lungs, is the second leading cause of death in COVID-19 patients, according to the National Center for Biotechnology Information.
May 4, 2021
You may have missed it during the throes of the COVID-19 pandemic, but the U.S. House of Representatives paid tribute last January to UC Davis distinguished professor Bruce Hammock, honoring his celebrated scientific research benefiting humankind--and also recognizing his legendary water balloon battles.